Introduction
The presently available mutagen test systems are no longer receiving critical acclaim by sole virtue of their positive response to ethyl methanesulfonate (EMS) . Rather, they are being asked to yield answers to such questions as: how mutagenic is EMS in this system and, given this number, what does it imply relative to the genetic risk of EMS to man? Both of these questions address themselves to the relevance of the test results, the first in a quantitative manner, the second qualitatively, in that it involves evaluating species' and systems' differences. Because this extrapolation of data must be to a rather complex organism-man-we are immediately'"face&'with-a-genetic quandary. Or'ganisms -which display thei-r'genetic repertoires in the simplest, most rapid manner-and which, therefore, are easiest to use and most definitive in the answers they yield-are phylogenetic foreigners to many.
Used alone, one risks banning penicillin on the basis of toxic effects on gram-positive bacteria, or, to cite an example more oriented to mutagenicity testing, one might be tempted to place 5- Subsequent studies onra 'different heteroThey grow well in suspension culture with zygote (TK+/--3.7.2) with a higher TK+'-a generation time of 10-11 hr; they dfone i -TK; spontaneous mutation rate (2 x with 80-100%o efficiency in a soft agar me-+ 10 mutations / locus / generation) show dium (2, 3) . We have found (3, 4) these cells the wide range of induced mutant frequento be diploid at the thymidine kinase (TK) cies to which this system can respond.- Figure  locus and have developed selection 'media 1 illustrates the relative mutagenicities of for isolating TK-competent 
Thymidine kinase activity, pmole thymidine phosphorylated/10' Spontaneous mutation rate, response range is-amplified in-theinset. Partial relief from such questions is obtained by replacing extracellular molar concentration of the mutagen as the independent variable in these figures by some parameter related to intracellular dose. In this manner the contribution to mutagenic response of The previous data can now be plotted over a common abscissal range (0-100%o growth inhibition) as in Figures 3 and 4 . Note (Fig.  4 ) that EMS appears to be a much more potent mutagen over the whole range of growth inhibitions covered, while MMS, hycanthone, and possibly even EDB fall fairly closely together.
These data are now in a format which is both quantitative and easily compared with Environmental Health Perspectivesother systems. If such comparisons show that the mutagenicity-toxicity relationships for a given compound are not too highly speciesdependent-or, if they are, and if wellestablished biochemical or physical difference in the more xenomorphic systems can adequately explain such differences-then the data can be directly extrapolated to man and an estimate of the genetic risk can be hazarded. The emphasis is, of course, on high correlations among various test systems after allowing for their respective pitfalls.
As a beginning in putting our mutagenicity test systems to positive social advantage we have been studying the mutagenicity of a number of hycanthone analogs possessing varying degrees of antischistosomal activity. The mutagenicity-or lack thereof-of one of these, IA-3 (the 6-chloroindazole derivative of lucanthone), is compared with that of hycanthone in Figure 5 as a function of both molar concentration and growth inhibition. At up to 80%o inhibition of growth this compound is no more than 10%oas muta- ing firm conclusions relative to clinical potential. Especially, the question of whether hydroxylation of the 4-methyl group occurs in whole mammals (as it does for lucanthone) must be considered, since the hydroxymethyl derivative of IA-3 is 3 times as mutagenic as IA-3 itself (i.e., it is 30%o as mutagenic as hycanthone). As alluded to above, these cells readily lend themselves to dosimetry studies at the genomal level. Specificially, Patterson (8) has determined the extent of ethylation of the DNA over a tenfold range in EMS concentration; by comparing these data with the EMS mutagenicity data an estimated 8 x 10-5 mutations per alkylation occur which is constant over a 5-fold concentration range (see Fig. 6 (9) or by utilizing these cells as indicator organisms in a host-mediated assay, as discussed by Capizzi (10) and Lee (11) .
Conclusions
The mammalian cell culture system just described helps bridge the gulf between microbial-especially prokaryotic-systems and whole mammal systems presently in use for mutagenicity studies. Such a claim follows from the fact that these lymphoma cells retain both a typically mammalian architecture (down to and including the genome) and certain facets of mammalian metabolism. Quantitative aspects of mutagenesis have been emphasized and mutagens can be classified as strong, weak, or of intermediate potency on the basis of their mutagenicity: growth inhibition curves. In an attempt to improve upon growth inhibition as a dosimetric measure, we have determined the relationship between extent of EMS-induced alkylation and resultant mutant frequency, and plan on extending such studies to other mutagens. Finally, a number of hycanthone analogs are being studied; one of these has been shown to exert possibly negligible mutagenicity at concentrations which are highly inhibitory to growth. It is hoped that such studies can lead to a safe hycanthone substitute for the control of schistosomiasis.
This workshop has demonstrated that basic agreement presently exists on the desirability of multiple test systems; multiple test systems exist, each with their characteristic strengths and weaknesses, for screening and safety testing programs; a possible hierarchv of such programs has been described by Bridges (12) . We can move on to the real world where mutagens do not attack in single file but en masse; where the target cells are not intraperitoneal, but gonadal; where the issue is not only dead fetuses, but an imperceptibly debilitating population; and where Salmonella sapiens does not exist.
